Main Sequence Ventures
Overview
Main Sequence Ventures is a venture capital investment firm that invests in deep tech spinouts, startups and company creation addressing global challenges . The firm works closely with scientists, researchers and industry collaborators to create, fund and accelerate new companies and industries across health, food, space, transport, security and deep tech to accelerate humanity for a more prosperous future .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Advanced Navigation | Mar 2026 | Series C | Co-investor |
| Gilmour Space | Jan 2026 | Series E | Co-investor |
| v2food | Aug 2021 | Series B Extension | - |
| Morse Micro | Sep 2025 | Series C | Co-investor |
| Kasada | Feb 2026 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Key People
Gabrielle Munzer
Partner
Phil Morle
Partner
Alezeia Brown
Investment Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Main Sequence Ventures based?
Main Sequence Ventures is headquartered in New South Wales.
When was Main Sequence Ventures founded?
Main Sequence Ventures was founded in 2017.
How many portfolio companies does Main Sequence Ventures have?
Main Sequence Ventures has 40 portfolio companies in Caplight's dataset.
What are some companies in Main Sequence Ventures's portfolio?
Portfolio companies visible on Caplight include Advanced Navigation, Gilmour Space, v2food, Morse Micro, Kasada.
What was Main Sequence Ventures's most recent investment shown here?
Main Sequence Ventures's most recent investment in this portfolio sample was in Advanced Navigation in 2026.
What sectors does Main Sequence Ventures focus on?
Main Sequence Ventures focuses on Healthcare & Life Sciences, Consumer & Commerce, Energy & Sustainability, Frontier & Industrial Tech, Healthcare & Life Sciences, Energy & Sustainability, Cybersecurity, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Crypto & Web3, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, Energy & Sustainability, Telecommunications & Networking, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Energy & Sustainability, Cybersecurity, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Healthcare & Life Sciences, Consumer & Commerce, Energy & Sustainability, Energy & Sustainability, Enterprise Software, Energy & Sustainability, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, Telecommunications & Networking, Mobility, Transportation & Logistics, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Telecommunications & Networking, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Enterprise Software, Energy & Sustainability, AI, Data & Cloud Infrastructure, Enterprise Software, FinTech, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Telecommunications & Networking, Enterprise Software, Energy & Sustainability.
What company stages does Main Sequence Ventures focus on?
Main Sequence Ventures typically invests at the Early stage.
What is Main Sequence Ventures's AUM?
Main Sequence Ventures's assets under management are estimated between $1.0B and $10.0B.